Production of full-length soluble Plasmodium falciparum RH5 protein vaccine using a Drosophila melanogaster Schneider 2 stable cell line system Capture ELISA using a panel of PfRH5-specific mAbs. Each mAb (6BF10, RB3, 8BB10, 9AD4 and QA1) was coated to the plate at a concentration of 5 µg/mL, and each PfRH5 protein variant was tested for binding using a dilution series of protein ranging from 800 ng/mL to 12.5 ng/mL. Each sample was tested in triplicate for each concentration. Bars show the median plus range. 
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